Literature DB >> 1554411

Effect of serum growth factors and phorbol ester on growth and survival of human thyroid epithelial cells expressing mutant ras.

J Bond1, T Dawson, N Lemoine, D Wynford-Thomas.   

Abstract

We previously demonstrated a high incidence of ras mutation in thyroid follicular (epithelial) cell neoplasms and showed that expression of mutant ras is a potent mitogenic stimulus for normal human follicular cells in culture. Here we show that induction of cell proliferation in primary follicular cells by a mutant human Ha-ras (val 12) expressed from a retroviral vector was absolutely dependent on the presence of serum growth factors. Induction of DNA synthesis showed partial dependence. Mutant ras-induced growth was also inhibited by exposure to phorbol ester at concentrations sufficient to downregulate protein kinase C. More importantly, we observed an unexpected toxic effect of phorbol ester in this system that was specific to cells expressing mutant ras. This has potential significance both for elucidating the basic mechanism of ras action in epithelial cells and also as a pointer to a novel therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554411     DOI: 10.1002/mc.2940050208

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  3 in total

Review 1.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

2.  Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis.

Authors:  J A Bond; M F Haughton; J M Rowson; P J Smith; V Gire; D Wynford-Thomas; F S Wyllie
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: a potential therapeutic target.

Authors:  C A Hall-Jackson; T Jones; N G Eccles; T P Dawson; J A Bond; A Gescher; D Wynford-Thomas
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.